Physical Activity and Cognitive Behavioural Therapy in Panic Disorder and Agoraphobia
Primary Purpose
Panic Disorder, Agoraphobia
Status
Completed
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
Cognitive Behavioural Therapy
Sponsored by
About this trial
This is an interventional treatment trial for Panic Disorder focused on measuring Panic Disorder, Agoraphobia, Physical Activity
Eligibility Criteria
Inclusion Criteria:
- Subject familiarized with experimental procedure and had given written informed consent
- Diagnosis of panic disorder with agoraphobia according to Diagnostic and Statistical Manual of Mental Disorders (DSM-IV)
- Score >= 18 in Hamilton Rating Scale for Anxiety
- Score >= 4 in Clinical Global Index
- Reachability of patient for treatment and follow-up
Exclusion Criteria:
- DSM-IV Axis I diagnoses of any psychotic disorder, bipolar disorder, current alcohol or drug dependence and Axis II borderline personality disorder
- Change in pharmacological treatment in the last 4 weeks
- Acute suicidality
- Medical contraindications for mild to moderate exercise training or exposure
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Active Comparator
Arm Label
70% VO2max
30% VO2max
Arm Description
Cognitive Behavioural Therapy (CBT) + aerobic exercise (30 minutes, 70% VO2max) prior to 5 in-vivo exposure sessions
Cognitive Behavioural Therapy (CBT) + placebo exercise (30 minutes, 30% VO2max) prior to 5 in-vivo exposure sessions
Outcomes
Primary Outcome Measures
Hamilton Rating Scale for Anxiety (CIPS 1995)
Global interviewer rated measure for anxiety and severity indicator of an anxiety disorder
Mobility Inventory (Chambless 1984)
A 27-item inventory for the measurement of self-reported agoraphobic avoidance behavior
Secondary Outcome Measures
Clinical Global Index (CIPS 1995)
Beck Depression Inventory (CIPS 1995)
Anxiety Sensitivity Index (Taylor 1998)
Body Sensations Questionnaire (Chambless 1984)
Agoraphobic Cognitions Questionaire (Chambless 1984)
Panic and Agoraphobia Scale
Severity scale for panic disorder
Full Information
NCT ID
NCT01928810
First Posted
July 26, 2013
Last Updated
February 6, 2015
Sponsor
Charite University, Berlin, Germany
Collaborators
German Federal Ministry of Education and Research
1. Study Identification
Unique Protocol Identification Number
NCT01928810
Brief Title
Physical Activity and Cognitive Behavioural Therapy in Panic Disorder and Agoraphobia
Official Title
The Influence of Physical Activity (Prior to In-vivo Exposure) on the Effect of Cognitive Behavioural Therapy in Patients With Panic Disorder and Agoraphobia
Study Type
Interventional
2. Study Status
Record Verification Date
February 2015
Overall Recruitment Status
Completed
Study Start Date
March 2011 (undefined)
Primary Completion Date
February 2014 (Actual)
Study Completion Date
February 2014 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Charite University, Berlin, Germany
Collaborators
German Federal Ministry of Education and Research
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
Physical activity (treadmill) prior to in-vivo exposure supports the effect of cognitive behavioural therapy in patients with panic disorder and agoraphobia.
Detailed Description
Patients receive a 12-session manualized cognitive behavioural therapy, implemented over 7 weeks and followed by two booster sessions. Five sessions consist of in-vivo exposures. Prior to these sessions patients undergo a training of physical activity. Half of the patients complete training on a treadmill at 70% of their maximal oxygen uptake while the other half complete training at 30%.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Panic Disorder, Agoraphobia
Keywords
Panic Disorder, Agoraphobia, Physical Activity
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
InvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
78 (Actual)
8. Arms, Groups, and Interventions
Arm Title
70% VO2max
Arm Type
Experimental
Arm Description
Cognitive Behavioural Therapy (CBT)
+ aerobic exercise (30 minutes, 70% VO2max) prior to 5 in-vivo exposure sessions
Arm Title
30% VO2max
Arm Type
Active Comparator
Arm Description
Cognitive Behavioural Therapy (CBT)
+ placebo exercise (30 minutes, 30% VO2max) prior to 5 in-vivo exposure sessions
Intervention Type
Behavioral
Intervention Name(s)
Cognitive Behavioural Therapy
Other Intervention Name(s)
CBT
Intervention Description
12 sessions of CBT including psychoeducation, interoceptive exposure and in-vivo exposure
Primary Outcome Measure Information:
Title
Hamilton Rating Scale for Anxiety (CIPS 1995)
Description
Global interviewer rated measure for anxiety and severity indicator of an anxiety disorder
Time Frame
Change from Baseline to 31 weeks (follow-up)
Title
Mobility Inventory (Chambless 1984)
Description
A 27-item inventory for the measurement of self-reported agoraphobic avoidance behavior
Time Frame
Change from Baseline to 31 weeks (follow-up)
Secondary Outcome Measure Information:
Title
Clinical Global Index (CIPS 1995)
Time Frame
Baseline, 3 weeks, 7 weeks, 31 weeks (follow up)
Title
Beck Depression Inventory (CIPS 1995)
Time Frame
Baseline, 3 weeks, 7 weeks, 31 weeks (follow up)
Title
Anxiety Sensitivity Index (Taylor 1998)
Time Frame
Baseline, every second session, 3 weeks, 7 weeks, 31 weeks (follow up)
Title
Body Sensations Questionnaire (Chambless 1984)
Time Frame
Baseline, 3 weeks, 7 weeks, 31 weeks (follow up)
Title
Agoraphobic Cognitions Questionaire (Chambless 1984)
Time Frame
Baseline, 3 weeks, 7 weeks, 31 weeks (follow up)
Title
Panic and Agoraphobia Scale
Description
Severity scale for panic disorder
Time Frame
Change from baseline to 31 weeks (follow-up)
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
65 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Subject familiarized with experimental procedure and had given written informed consent
Diagnosis of panic disorder with agoraphobia according to Diagnostic and Statistical Manual of Mental Disorders (DSM-IV)
Score >= 18 in Hamilton Rating Scale for Anxiety
Score >= 4 in Clinical Global Index
Reachability of patient for treatment and follow-up
Exclusion Criteria:
DSM-IV Axis I diagnoses of any psychotic disorder, bipolar disorder, current alcohol or drug dependence and Axis II borderline personality disorder
Change in pharmacological treatment in the last 4 weeks
Acute suicidality
Medical contraindications for mild to moderate exercise training or exposure
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Sophie Bischoff, Dipl.-Psych.
Organizational Affiliation
Charite
Official's Role
Principal Investigator
12. IPD Sharing Statement
Links:
URL
http://www.angstambulanz-charite.de/
Description
Related Info
Learn more about this trial
Physical Activity and Cognitive Behavioural Therapy in Panic Disorder and Agoraphobia
We'll reach out to this number within 24 hrs